Basics |
Thermo Fisher Scientific, Inc.
Thermo Fisher Scientific Inc is a healthcare company. It offers analytical instruments, laboratory equipment, software, services, consumables, reagents and chemicals.
|
IPO Date: |
January 2, 1990 |
Sector: |
Healthcare |
Industry: |
Life Sciences Tools and Services |
Market Cap: |
$152.34B |
Activated in VL: |
True |
Average Daily Range |
Avg Daily Range: |
$1.96 | 0.99%
|
Avg Daily Range (30 D): |
$5.97 | 1.41%
|
Avg Daily Range (90 D): |
$6.90 | 1.46%
|
Institutional Daily Volume |
Avg Daily Volume: |
1.83M |
Avg Daily Volume (30 D): |
2.39M |
Avg Daily Volume (90 D): |
1.96M |
Trade Size |
Avg Trade Size (Sh.): |
98 |
Avg Trade Size (Sh.) (30 D): |
41 |
Avg Trade Size (Sh.) (90 D): |
38 |
Institutional Trades |
Total Inst.Trades: |
37,007 |
Avg Inst. Trade: |
$10.71M |
Avg Inst. Trade (30 D): |
$26.23M |
Avg Inst. Trade (90 D): |
$32.32M |
Avg Inst. Trade Volume: |
.05M |
Avg Inst. Trades (Per Day): |
6 |
Market Closing Trades |
Avg Closing Trade: |
$50.51M |
Avg Closing Trade (30 D): |
$127.42M |
Avg Closing Trade (90 D): |
$134.44M |
Avg Closing Volume: |
163.42K |
|
|
|
|
Financials |
|
TTM |
Q1 2025 |
Q4 2024 |
Basic EPS
|
$17.09
|
$3.99
|
$4.79
|
Diluted EPS
|
$17.05
|
$3.98
|
$4.78
|
Revenue
|
$ 42.9B
|
$ 10.36B
|
$ 11.4B
|
Gross Profit
|
$
|
$
|
$
|
Net Income / Loss
|
$ 6.52B
|
$ 1.51B
|
$ 1.82B
|
Operating Income / Loss
|
$ 7.39B
|
$ 1.72B
|
$ 2.02B
|
Cost of Revenue
|
$
|
$
|
$
|
Net Cash Flow
|
$ -1272M
|
$ 94M
|
$ -356M
|
PE Ratio
|
23.23
|
|
|
|